Agenus Inc Stock Analysis

Agenus Stock Analysis Notes

About 37.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 12.28. Agenus Inc last dividend was issued on the 29th of October 2010. The entity had 1:20 split on the 12th of April 2024. Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts. Agenus operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 441 people. For more info on Agenus Inc please contact Garo Armen at 781 674 4400 or go to https://www.agenusbio.com.

Agenus Inc Investment Alerts

Agenus Inc Upcoming and Recent Events

Agenus Thematic Classifications

Agenus Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 92.09 M.

Agenus Profitablity

The company has Profit Margin (PM) of (1.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.33) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.33.

Technical Drivers

As of the 7th of February, Agenus shows the risk adjusted performance of 0.0254, and Mean Deviation of 4.8. Agenus Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Agenus Inc Price Movement Analysis

Agenus Inc Insider Trading Activities

Agenus Outstanding Bonds

Agenus Predictive Daily Indicators

Agenus Forecast Models

Agenus' time-series forecasting models are one of many Agenus' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Agenus' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Agenus prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Agenus shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Agenus. By using and applying Agenus Stock analysis, traders can create a robust methodology for identifying Agenus entry and exit points for their positions.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Agenus Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Agenus. If investors know Agenus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Agenus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Agenus Inc is measured differently than its book value, which is the value of Agenus that is recorded on the company's balance sheet. Investors also form their own opinion of Agenus' value that differs from its market value or its book value, called intrinsic value, which is Agenus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Agenus' market value can be influenced by many factors that don't directly affect Agenus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Agenus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Agenus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Agenus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.